Treatment of Vasovagal Syncope
PDF
Cite
Share
Request
Review
VOLUME: 1 ISSUE: 3
P: 184 - 190
December 2013

Treatment of Vasovagal Syncope

Namik Kemal Med J 2013;1(3):184-190
1. Dumlupınar Üniversitesi Tıp Fakültesi Kardiyoloji Anabilim Dalı, Kütahya, Türkiye
No information available.
No information available
Received Date: 02.07.2013
Accepted Date: 17.09.2013
PDF
Cite
Share
Request

ABSTRACT

Vasovagal syncope (VVS) is the most common cause of recurrent syncope which has a good prognosis, but has a high morbidity. structural heart disease is absent in most of the patients. It is thought to be the result of neurocardiovascular system abnormality which provides the systemic and cerebral perfusion. Although VVS has a high incidence, no satisfactory treatment has been found yet. The main purpose of the treatment is to prevent the recurrent syncope episodes and injuries that may occur due to syncope and to improve the quality of life. Treatment of VVS is divided into three as nonpharmacological treatment, pharmacological treatment and cardiac pacemaker implantation. The treatment of VVS is difficult. The patient should be given detailed information about the disease, proper diet should be recommended by the life-style changes, triggerering factors of the syncope should be explained and advised to avoid these triggers. Psychological support is very important and should be maintained in these patients. Patients should be strongly encouraged to implement physical maneuvers. Medical treatment can be tried if the patients’ complaints continue. In case of recurrent syncope despite ongoing medical treatment, permanent pacemaker implantation should be considered.

Keywords:
Neurocardiovascular, syncope